Gamma

Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Retrieved on: 
星期二, 五月 7, 2024
FDA, Amyloid beta, Part, Total, PIPE, CDER, Transferrin receptor, Nerve, BBB, CSF, Biomarker, Gamma, Enzyme replacement therapy, Traffic barrier, Hunting, OTV, PTV, Food, MGH, IDS, Conference, MAPT, ALS, Therapy, Cerebrospinal fluid, SAN, MPS II, Hospital, Safety, AFL, SGSH, UC, Alpha-synuclein, LUMA, SNCA, Clinical trial, Glycogen storage disease, Neurodegenerative disease, MPS, COMPASS, Patient, Alfa, Acquisition, ETV, ATV, Hunter syndrome, Sanofi, Massachusetts General Hospital, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for the treatment of neurodegenerative diseases and lysosomal storage diseases, today reported financial results for the first quarter ended March 31, 2024, and provided business highlights.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for the treatment of neurodegenerative diseases and lysosomal storage diseases, today reported financial results for the first quarter ended March 31, 2024, and provided business highlights.
  • There was no collaboration revenue for the quarter ended March 31, 2024, compared to $35.1 million for the quarter ended March 31, 2023.
  • Total research and development expenses were $107.0 million for the quarter ended March 31, 2024, compared to $128.8 million for the quarter ended March 31, 2023.
  • General and administrative expenses were $25.2 million for the quarter ended March 31, 2024, compared to $27.1 million for the quarter ended March 31, 2023.

Nuclear Fuels Announces Resumption of Drilling at Its Kaycee ISR Uranium Project, Powder River Basin, Wyoming

Retrieved on: 
星期一, 四月 29, 2024
Gamma, ICP-MS, Uranium, News, Nuclear Regulatory Commission, State government, National Instrument 43-101, Federation, Fuel pump, PRB, National instrument, ISR, CPG, Uranium mining

To view the Kaycee uranium drill program video please visit: Kaycee Project- Nuclear Fuels (youtube.com) and for more frequent updates, follow us on Instagram, X, Facebook and LinkedIn.

Key Points: 
  • To view the Kaycee uranium drill program video please visit: Kaycee Project- Nuclear Fuels (youtube.com) and for more frequent updates, follow us on Instagram, X, Facebook and LinkedIn.
  • The Kaycee Project, under Nuclear Fuels, represents the first time since the early 1980's that the entire district is controlled by one company.
  • Wyoming is a proven and prolific uranium producer with a pro-energy government and established regulatory regime for the permitting and extraction of uranium through ISR technology.
  • Comparisons of U3O8 Gamma log and ICP-MS assays of Powder River Basin core samples indicate that U3O8 Gamma is comparable to ICP-MS uranium assay in the Powder River Basin.

Standard Uranium Reports on Recent Exploration Insights at the Sun Dog Project with Option Partner Aero Energy Ltd.

Retrieved on: 
星期二, 四月 16, 2024
MWH, Project, UAV, Boron, Unconformity, Gamma, Athabasca Basin, Contract management, Uranium, Element, Nature, History, News, Radioactive decay, Tourmaline, AERO, CPS, TSX, Magnetism, Exercise, Gold, Anomaly, Soil, Mining, Vein, Arrow, Gunnar Mine, Uranium mining

VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“Standard Uranium” or the “Company”) (TSX-V: STND) (OTCQB: STTDF) (Frankfurt: FWB:9SU) is pleased to provide a comprehensive summary of exploration insights and historical data gathered at its Sun Dog Uranium Project (“Sun Dog”, or the “Project”), currently under a three-year earn-in option agreement with Aero Energy Ltd. (“Aero”) (TSX-V: AERO).

Key Points: 
  • VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“Standard Uranium” or the “Company”) (TSX-V: STND) (OTCQB: STTDF) (Frankfurt: FWB:9SU) is pleased to provide a comprehensive summary of exploration insights and historical data gathered at its Sun Dog Uranium Project (“Sun Dog”, or the “Project”), currently under a three-year earn-in option agreement with Aero Energy Ltd. (“Aero”) (TSX-V: AERO).
  • Jon Bey, CEO of Standard Uranium, commented: “We are thrilled to return to the Sun Dog Project and continue advancing our exploration strategy targeting prospective high-grade uranium targets.
  • Sun Dog Project Overview and Historical Exploration:
    The Project is currently under option (the “Option”) to Aero Energy Ltd. (the “Optionee”) an arms-length company (TSX-V: AERO).
  • Historical data disclosed in this news release relating to sampling results on the Sun Dog Project is historical in nature.

Standard Uranium Intersects Anomalous Radioactivity, Prospective Structure and Alteration in Multiple Drill Holes at Atlantic Project; Concludes Inaugural Drill Program

Retrieved on: 
星期四, 四月 11, 2024
ICP-MS, Standards Council of Canada, Digestion, Uranium, Gamma, Boron, Denison Mines, News, Rock, Tourmaline, Hematite, Hole, CPS, QA/QC, Gold, SRC, Anomaly, Radioactive decay, UC, Uranium mining

Core photos of prospective alteration, structure, and radioactivity intersected during the inaugural drill program are presented in Figure 3, 4, and 5.

Key Points: 
  • Core photos of prospective alteration, structure, and radioactivity intersected during the inaugural drill program are presented in Figure 3, 4, and 5.
  • Core photos from drill hole ATL-24-002 highlighting significant structure and alteration intersected in the Athabasca sandstone and basement rocks.
  • Core photos from drill hole ATL-24-004a highlighting basement structure and alteration zones intersected associated with anomalous radioactivity.
  • Core photos from drill hole ATL-24-005a highlighting structure and alteration intersected in the Athabasca sandstone and basement rocks.

VIETNAMESE SOLAR TECHNOLOGY LEADER SELECTS NORTH CAROLINA FOR FIRST NORTH AMERICAN PRODUCTION FACILITY

Retrieved on: 
星期五, 四月 26, 2024
Gamma, PV, Topcon, Hand axe, Panel data, The Company, Marketing, ESG, Economic development, Workforce, Quality of life, SAN, Renewable energy

Boviet Solar selects North Carolina for its first North American production facility.

Key Points: 
  • Boviet Solar selects North Carolina for its first North American production facility.
  • "Our dreams of producing our PV modules in the U.S. finally come to realization," said Jimmy Xie, General Manager of Boviet Solar.
  • "We are proud of bringing our manufacturing excellence to our most important solar market, creating jobs, and making a positive impact on North Carolina's economy.
  • "It's great to welcome Boviet Solar to North Carolina," said North Carolina Governor Roy Cooper.

Eldon James Corp launches SeriesLock® XGen™ at Interphex in New York

Retrieved on: 
星期二, 四月 16, 2024
Gamma, Housing, ISO, ID, PSU, Autoclave, Sterilization, Hydraulic machinery

FORT COLLINS, Colo., April 16, 2024 /PRNewswire-PRWeb/ -- Eldon James Corporation launches SeriesLock® XGen™ at the Interphex show, Booth #1403, in New York. This is the next generation in genderless connectors. This intuitive, easy to use genderless sterile quick-disconnect solution allows for disconnects and reconnect up to 10 times. This spring-free flow path® genderless connector allows a larger volume of fluid to pass through at lower line pressures. XGen genderless quick connect technology is revolutionizing the bioprocessing industry by offering a more efficient, versatile, and reliable solution for connecting equipment and processes.

Key Points: 
  • FORT COLLINS, Colo., April 16, 2024 /PRNewswire-PRWeb/ -- Eldon James Corporation launches SeriesLock® XGen™ at the Interphex show, Booth #1403, in New York.
  • This intuitive, easy to use genderless sterile quick-disconnect solution allows for disconnects and reconnect up to 10 times.
  • This spring-free flow path® genderless connector allows a larger volume of fluid to pass through at lower line pressures.
  • Recessed mating features protect contact surfaces and allow for a no drip, sterile connection, or reconnection even in gray spaces.

BOVIET SOLAR TO EXHIBIT FOR THE FIRST TIME AT ACP CLEAN POWER TRADE CONFERENCE IN MINNEAPOLIS, MN, USA

Retrieved on: 
星期一, 四月 15, 2024
Gamma, PV, Topcon, Panel data, Exhibition, The Company, PERC, Vega, ESG, Convention, SAN, Renewable energy

Boviet Solar's exhibition booth 3420 will be located in the main Exhibit Hall.

Key Points: 
  • Boviet Solar's exhibition booth 3420 will be located in the main Exhibit Hall.
  • Boviet Solar's exhibition booth will be located in the main Exhibit Hall and booth number is 3420.
  • Boviet Solar will present its TOPCon and PERC cell-based Vega Series™ Mono-Bifacial and Gamma Series™ Mono-Monofacial PV Modules during the exhibition.
  • Boviet Solar has been a Bloomberg New Energy Finance Tier 1 PV Module Manufacturer since 2017.

Adaptive Sound Technologies, Inc. Launches Sound+Therapy, Their Latest And Most Effective Science-Backed Sleep Sound Machine

Retrieved on: 
星期四, 四月 11, 2024
Relaxation, Acute stress disorder, Gamma, Brain, ASTI, Trial of the century, Neurology, Hertz, EEG, Sleep, Medical imaging

CAMPBELL, Calif., April 11, 2024 /PRNewswire/ -- SOUND+THERAPY is a natural sleep solution replicating ancient sound therapy techniques by generating proprietary "beat sounds" with a fundamental frequency of 40 Hertz (Hz). This frequency has been shown in multiple studies to promote sleep and relaxation. Due to the complexity of producing these custom beat sounds, ASTI sound experts have developed a specialized speaker that can generate this low frequency at an affordable cost. 

Key Points: 
  • SOUND + THERAPY is a high-quality bedside device that uses precise 40 Hertz gamma sound and light therapy to promote better sleep.
  • SOUND+THERAPY is a bedside device that uses precise 40 Hertz gamma sound and light therapy to promote better sleep.
  • 40 Hz, also called Gamma sound therapy, reinforces naturally occurring frequencies in the brain that are important for various cognitive functions.
  • Notably, there was a marked enhancement in sleep maintenance, with a reduction in awakenings after the onset of sleep and an overall increase in sleep efficiency.

RocketStar Announces Successful Demonstration of Fusion-Enhanced Pulsed Plasma Electric Propulsion

Retrieved on: 
星期三, 三月 20, 2024
Nuclear fusion, Radiation, USSF, Plasma, Georgia Tech, Boron, Proton, SBIR, University, Spacecraft, OTV, Carbon, AFWERX, Nuclear engineering, Alpha, Firestar, Gamma, SpaceX, ION Satellite Carrier, Lithium

NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- RocketStar Inc. has successfully demonstrated the FireStar Drive, a groundbreaking electric propulsion unit for spacecraft that uses nuclear fusion-enhanced pulsed plasma.

Key Points: 
  • NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- RocketStar Inc. has successfully demonstrated the FireStar Drive, a groundbreaking electric propulsion unit for spacecraft that uses nuclear fusion-enhanced pulsed plasma.
  • This innovative device significantly boosts the performance of RocketStar's base water-fueled pulsed plasma thruster by utilizing a unique form of aneutronic nuclear fusion.
  • The fusion discovery was first made during an SBIR Phase 1 for AFWERX where boronated water was introduced into the pulsed plasma thruster’s exhaust plume.
  • “We are very excited to test FireStar for RocketStar,” said Brent Abbott, CRO at Rogue Space Systems.

Stryker launches Gamma4 Hip Fracture Nailing System in Europe

Retrieved on: 
星期二, 三月 26, 2024
General Health, Surgery, Medical Devices, Health, Health Technology, Certification, Database, Gamma, CE, Hip, Fracture, Femur, Surgeon, Workflow, Trochanter, SYK, Precision, Multimedia, Nail, Feedback

Stryker (NYSE:SYK), a global leader in medical technologies, today announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets.

Key Points: 
  • Stryker (NYSE:SYK), a global leader in medical technologies, today announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets.
  • The newest Gamma system will provide surgeons with the next generation of Stryker’s intramedullary nailing system.
  • The Gamma4 system is designed to treat hip and femur fractures and streamline procedural workflows for surgeons.
  • The new Gamma4 system redefines hip fracture care with sleek instrumentation, advanced nail design and improved geometry collectively, ensuring a lasting impact on orthopaedic practices for years to come.”